• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study.

作者信息

Hardy Michael, Michaux Isabelle, Dive Alain, Lecompte Thomas, Mullier François

机构信息

Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium.

Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Anesthesiology Department, Yvoir, Belgium.

出版信息

TH Open. 2021 May 12;5(2):e152-e154. doi: 10.1055/s-0041-1728722. eCollection 2021 Apr.

DOI:10.1055/s-0041-1728722
PMID:34007953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8116170/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e6f/8116170/53e426348920/10-1055-s-0041-1728722-i210010-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e6f/8116170/53e426348920/10-1055-s-0041-1728722-i210010-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e6f/8116170/53e426348920/10-1055-s-0041-1728722-i210010-1.jpg

相似文献

1
Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study.每日监测纤维蛋白相关标志物能否有助于怀疑COVID-19患者发生血栓形成事件？一项前瞻性试点研究。
TH Open. 2021 May 12;5(2):e152-e154. doi: 10.1055/s-0041-1728722. eCollection 2021 Apr.
2
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.2019 年冠状病毒病（Covid-19）中的动脉和静脉血栓形成：与死亡率的关系。
Intern Emerg Med. 2021 Aug;16(5):1231-1237. doi: 10.1007/s11739-020-02621-8. Epub 2021 Jul 4.
3
Soluble fibrin as a molecular marker for a pre-thrombotic state: a mini-review.
Blood Coagul Fibrinolysis. 1993 Feb;4(1):93-6.
4
Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.Covid-19：纤维蛋白（ogen）、D-二聚体、血管性血友病因子、P-选择素及其与内皮细胞、血小板和红细胞相互作用的过山车。
Int J Mol Sci. 2020 Jul 21;21(14):5168. doi: 10.3390/ijms21145168.
5
Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome.血浆纤维蛋白凝块通透性降低与抗磷脂综合征患者复发性血栓栓塞事件相关。
Rheumatology (Oxford). 2018 Aug 1;57(8):1340-1349. doi: 10.1093/rheumatology/key089.
6
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
7
Nonvalvular atrial fibrillation: evidence for a prothrombotic state.非瓣膜性心房颤动：血栓前状态的证据。
CMAJ. 1997 Sep 15;157(6):673-81.
8
Anticoagulation in COVID - 19: An Update.2019冠状病毒病的抗凝治疗：最新进展
J Crit Care Med (Targu Mures). 2020 Nov 7;6(4):217-223. doi: 10.2478/jccm-2020-0033. eCollection 2020 Oct.
9
Virgin coconut oil is effective in lowering C-reactive protein levels among suspect and probable cases of COVID-19.初榨椰子油对降低COVID-19疑似和可能病例的C反应蛋白水平有效。
J Funct Foods. 2021 Aug;83:104557. doi: 10.1016/j.jff.2021.104557. Epub 2021 May 24.
10
[Pre-Thrombotic (Hypercoagulable) State/Hypercoagulable Disease].[血栓前（高凝）状态/高凝疾病]
Rinsho Byori. 2015 Dec;63(12):1405-11.

引用本文的文献

1
COVID-19 and the Concept of Thrombo-Inflammation: Review of the Relationship between Immune Response, Endothelium and Coagulation.2019冠状病毒病与血栓炎症概念：免疫反应、内皮细胞与凝血之间关系的综述
J Clin Med. 2023 Nov 23;12(23):7245. doi: 10.3390/jcm12237245.
2
Fibrin monomers evaluation during hospitalization for COVID-19 is a predictive marker of in-hospital mortality.新冠病毒疾病住院期间纤维蛋白单体评估是院内死亡率的预测指标。
Front Cardiovasc Med. 2023 Mar 30;10:1001530. doi: 10.3389/fcvm.2023.1001530. eCollection 2023.
3
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply 'hyperfibrinolysis'.

本文引用的文献

1
Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.纤维蛋白/纤维蛋白原降解产物试剂的特性及其在伴有纤维蛋白溶解增强的重症监护患者中的应用。
Int J Lab Hematol. 2021 Aug;43(4):813-820. doi: 10.1111/ijlh.13428. Epub 2020 Dec 10.
2
Retrospective Analyses Associate Hemostasis Activation Biomarkers With Poor Outcomes in Patients With COVID-19.回顾性分析将止血激活生物标志物与 COVID-19 患者的不良预后相关联。
Am J Clin Pathol. 2021 Mar 15;155(4):498-505. doi: 10.1093/ajcp/aqaa266.
3
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data.
别被D-二聚体误导：血浆D-二聚体水平升高并不意味着“高纤维蛋白溶解”。
Thromb Res. 2022 Jun;214:63-64. doi: 10.1016/j.thromres.2022.04.012. Epub 2022 Apr 25.
4
Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study.比较纤维蛋白单体和D-二聚体以预测COVID-19肺炎重症患者的血栓形成事件：一项回顾性研究。
Thromb Res. 2021 Sep;205:8-10. doi: 10.1016/j.thromres.2021.06.009. Epub 2021 Jun 19.
重症 COVID-19 患者的血栓前止血紊乱：个体每日数据。
Data Brief. 2020 Dec;33:106519. doi: 10.1016/j.dib.2020.106519. Epub 2020 Nov 10.
4
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.重症新型冠状病毒肺炎患者止血的血栓前状态紊乱：一项前瞻性纵向观察研究。
Thromb Res. 2021 Jan;197:20-23. doi: 10.1016/j.thromres.2020.10.025. Epub 2020 Oct 24.
5
D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.成人新冠肺炎住院患者的D-二聚体临界值与静脉血栓栓塞风险
Thromb Res. 2020 Dec;196:318-321. doi: 10.1016/j.thromres.2020.09.022. Epub 2020 Sep 17.
6
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。
Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.
7
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.D-二聚体及中等剂量预防措施在COVID-19危重症患者静脉血栓栓塞中的应用价值
Thromb Res. 2020 Dec;196:222-226. doi: 10.1016/j.thromres.2020.08.027. Epub 2020 Aug 21.
8
Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients.D-二聚体升高和未抗凝与重症 COVID-19 患者的 PE 相关。
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.01811-2020. Print 2020 Oct.
9
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.COVID-19 患者的入院 D-二聚体水平、D-二聚体趋势和结局。
Thromb Res. 2020 Dec;196:99-105. doi: 10.1016/j.thromres.2020.08.032. Epub 2020 Aug 20.
10
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.